A Multicentre, Double-Blind, Prospective, Randomised, European and Canadian Study to Evaluate Patient Outcomes and Costs of Managing Adults with Spasticity and Associated Focal Spasticity.

Trial Profile

A Multicentre, Double-Blind, Prospective, Randomised, European and Canadian Study to Evaluate Patient Outcomes and Costs of Managing Adults with Spasticity and Associated Focal Spasticity.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Jul 2016

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Spastic paralysis; Stroke complications
  • Focus Registrational; Therapeutic Use
  • Acronyms BEST
  • Sponsors Allergan
  • Most Recent Events

    • 01 Jul 2016 Status changed to active, no longer recruiting.
    • 18 Jun 2015 Results (pain response) presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
    • 13 Sep 2011 Resource use results presented at the 15th Congress of the European Federation of Neurological Societies.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top